Citations 1
Long‐term safety with ≥12 months of pirtobrutinib in relapsed/refractory B‐cell malignancies
Wang, Y., Coombs, Catherine C. , Shah, Nirav N. , Woyach, Jennifer A. , Maddocks, Kami J. , Muehlenbein, Catherine E. , Abhyankar, S., Tsai, Donald E. , Eyre, Toby A. , Wang, Yucai , Jurczak, Wojciech , Cheah, Chan Y. , Patel, Krish , Wang, C.
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 480-481
